Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria.
Saved in:
| Title: | Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria. |
|---|---|
| Authors: | Jansson Sigfrids F; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Stechemesser L; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; First Department of Medicine, Paracelsus Medical University, Salzburg, Austria., Dahlström EH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Forsblom CM; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Harjutsalo V; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; National Institute for Health and Welfare, Helsinki, Finland., Weitgasser R; First Department of Medicine, Paracelsus Medical University, Salzburg, Austria.; Department of Medicine, Diabetology, Wehrle-Diakonissen Hospital, Salzburg, Austria., Taskinen MR; Heart and Lung Centre, University of Helsinki, Helsinki, Finland., Groop PH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.; Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia. |
| Corporate Authors: | FinnDiane Study Group; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland. |
| Source: | Journal of internal medicine [J Intern Med] 2022 Mar; Vol. 291 (3), pp. 338-349. Date of Electronic Publication: 2021 Nov 24. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2796 |
|---|---|
| DOI: | 10.1111/joim.13412 |
